IRVINE, Calif., Jan. 26, 2009 (GLOBE NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today announced that it has further extended its international reach to encompass five additional global markets. In addition to the 24 countries where SenoRx products are already being sold internationally, the company will begin marketing EnCor(r), its vacuum-assisted breast biopsy product, and its GelMark(tm) line of breast biopsy tissue markers through distributors in Egypt, Greece, Poland, Saudi Arabia, Thailand, Turkey and the United Arab Emirates.
